ActiGraph, which makes digital tools used in clinical trials, acquired the life sciences business of Biofourmis, once considered a digital health unicorn.

ActiGraph executives spoke with STAT about getting a drug approved with a digital endpoint in a clinical trial using wearables.

ActiGraph, the global leader in wearable digital health technology for clinical research and development, has announced the acquisition of Biofourmis Connect, a division of Biofourmis that ...

Garmin International, Inc. recently announced a collaboration with ActiGraph to create health and activity monitoring solutions for academic research, ...

ArchiMed acquired ActiGraph, which provides wearable, remote monitoring of mobility and sleep for drug trials. ArchiMed is buying 75 percent of ActiGraph in an all-equity deal, with company ...

Edgemont Partners served as exclusive financial advisor to ActiGraph in its sale to ArchiMed.

This baby’s cry in the sky wasn’t going to fly. A mom has gone viral on Instagram after sharing a video of her husband making their 5-month-old daughter apologize to fellow fliers following a ...

The Actigraph Monitor is the size of a matchbox and is worn around the waist. The device counts the up-and-down movement as children, walk, run or engage in other physical activity.

Garmin Health and ActiGraph are partnering on clinical trials that could eventually result in a much more accurate and comprehensive system for monitoring health metrics using wearables. The ...

A recent independent evaluation of accelerometry data has shown the ActiGraph to be the most accurate commercially available device to assess daily physical activity.

The wrist-worn ActiGraph wGT3x-BT in combination with body composition variables explained up to the 62% of the variation in AEE.